Jeil Pharmaceutical Co., Ltd. (271980) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Jeil Pharmaceutical Co., Ltd. (271980:KRX), powered by AI.

Current Price
₩10,700
P/E Ratio
6.7
Market Cap
157.3B
Sector
Healthcare
What is the Jeil Pharmaceutical Co., Ltd. stock price forecast?

Jeil Pharmaceutical Co., Ltd. is currently trading at ₩10,700. View real-time AI analysis on Alpha Lenz.

What is Jeil Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Jeil Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Jeil Pharmaceutical Co., Ltd.'s P/E ratio?

Jeil Pharmaceutical Co., Ltd.'s P/E ratio is 6.7.

Jeil Pharmaceutical Co., Ltd.

KRX · 271980
₩10,700+470(+4.59%)Market closedKRX regular session 09:00–15:30 KST
Ask about Jeil Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Jeil Pharmaceutical Co., Ltd. trades at a P/E of 6.7 (undervalued) with solid ROE of 11.7%.

Ask for details

Company Overview

Jeil Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, specializing in the research, development, and manufacturing of a wide array of medications. Established as a key figure within the healthcare sector, Jeil Pharmaceutical focuses on providing innovative and effective pharmaceuticals to enhance public health and quality of life. The company is involved in the production of both prescription and over-the-counter drugs, catering to diverse therapeutic areas such as cardiovascular, gastrointestinal, and metabolic disorders. Jeil Pharmaceutical is noted for its commitment to R&D, consistently investing in the development of new drugs and biosimilars, which helps in maintaining its competitive edge in a dynamic marketplace. The company operates within a robust regulatory framework, adhering to stringent quality standards to ensure the safety and efficacy of its products. In the financial market, Jeil Pharmaceutical Co., Ltd. plays a significant role as it contributes to the vitality of the healthcare ecosystem by addressing essential medical needs and offering healthcare solutions globally.

CEO성석제, 한상철 (공동대표)
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees947

Company Statistics

FY 2025

Profile

₩157,342,130,400Market Cap
₩567,244,440,280Revenue
14.70MShares Out
947Employees

Margins

37.53%Gross
8.93%EBITDA
3.70%Operating
6.16%Pre-Tax
5.64%Net

Valuation

6.73P/E
0.75P/B
0.28EV/Sales
4.77EV/EBITDA
-10.66P/FCF

Growth (CAGR)

-7.74%Rev 3Yr
-3.88%Rev 5Yr
N/AOp Inc 3Yr
10.22%Op Inc 5Yr
N/ANet Inc 3Yr
35.66%Net Inc 5Yr

Returns

6.18%ROA
11.71%ROE
7.59%ROIC

Financial Health

₩48,874,196,060Cash & Cash Equivalents
₩210,675,293,550Net Debt
103.40%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Jeil Pharmaceutical Co., Ltd. (ticker: 271980) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 947 employees. Market cap is $157.3B.

The current price is ₩10,700 with a P/E ratio of 6.73x and P/B of 0.75x.

ROE is 11.71% and operating margin is 3.70%. Annual revenue is $567.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Jeil Pharmaceutical Co., Ltd. (271980) Stock Forecast 2026 ₩10,700 — Price, Financials & Analyst Targets | Alpha Lenz